What is the price target for JSPR stock?
14 analysts have analysed JSPR and the average price target is 8.93 USD. This implies a price increase of 824.01% is expected in the next year compared to the current price of 0.9659.
JASPER THERAPEUTICS INC (JSPR) Forecast, Price Target & Analyst Ratings
NASDAQ:JSPR • US4718712023
Current stock price
0.9659 USD
-0.08 (-8.01%)
At close:
0.9659 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for JASPER THERAPEUTICS INC (JSPR).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.52
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$8.93
Upside
+ 824.01%
From current price of $0.97 to mean target of $8.93, Based on 14 analyst forecasts
Low
$1.52
Median
$6.63
High
$21.00
Price Target Revisions
1 Month
-30.92%
3 Months
-30.92%
Price Target Summary
14 Wall Street analysts provided a forecast for the next 12 months for JSPR. The average price target is 8.93 USD. This implies a price increase of 824.01% is expected in the next year compared to the current price of 0.9659.
The average price target has been revised downward by 30.92% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
78.57%
JSPR was analyzed by 14 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about JSPR.
In the previous month the buy percentage consensus was at a similar level.
JSPR was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-01 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-11-11 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-09-22 | BTIG | Maintains | Buy -> Buy |
| 2025-09-22 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-09-22 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-08-15 | UBS | Maintains | Buy -> Buy |
| 2025-07-08 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2025-07-08 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-07-08 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-07-07 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2025-07-07 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-07-07 | BTIG | Maintains | Buy -> Buy |
| 2025-07-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-15 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-13 | UBS | Maintains | Buy -> Buy |
| 2025-03-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-13 | UBS | Initiate | Buy |
| 2025-01-10 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-01-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-09 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-01-06 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-12-23 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-12-06 | BMO Capital | Initiate | Outperform |
| 2024-10-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.52
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 63.25%
- Number of Analysts
- 5
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
29.74%
EPS (3 Months)
29.74%
Next Earnings Summary
JSPR is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.52 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A -32.59% | N/A 213.92% | N/A 162.83% | N/A 67.93% | ||||||||
| EBITDA YoY % growth | N/A | N/A | -36.456M | -50.221M -37.76% | -67.753M -34.91% | -74.866M -10.50% | -81.727M -9.16% | N/A 3.64% | N/A -4.84% | N/A -12.75% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -4.71M | -20.683M -339.13% | -36.833M -78.08% | -51.196M -38.99% | -68.861M -34.50% | -76.239M -10.71% | -82.783M -8.58% | N/A -10.97% | N/A -28.01% | N/A -9.13% | N/A 7.56% | N/A -23.19% | N/A 61.10% | N/A 189.14% | N/A 112.58% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -10.30 55.00% | -6.20 39.81% | -4.86 21.61% | -4.72 2.88% | N/A 59.04% | N/A -2.22% | N/A 39.87% | N/A 47.21% | N/A -43.09% | N/A 12.50% | N/A 68.83% | N/A 245.83% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.52 63.25% | -0.55 68.48% | -0.62 50.71% | -0.80 -149.05% | -0.79 -51.57% | -0.77 -39.49% | -0.79 -27.48% | -0.80 0.17% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -17.163M 21.28% | -18.199M 32.79% | -19.707M -2.82% | -25.068M -70.08% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
20.47%
EPS Next 5 Year
12.60%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-1.88%
EBIT Next 5 Year
N/A
JASPER THERAPEUTICS INC / JSPR Forecast FAQ
Can you provide the upcoming earnings date for JASPER THERAPEUTICS INC?
JASPER THERAPEUTICS INC (JSPR) will report earnings on 2026-05-11, before the market open.
What are the consensus estimates for JASPER THERAPEUTICS INC (JSPR) next earnings?
The consensus EPS estimate for the next earnings of JASPER THERAPEUTICS INC (JSPR) is -0.52 USD and the consensus revenue estimate is 0 USD.
Can you provide the analyst count for JASPER THERAPEUTICS INC stock?
The number of analysts covering JASPER THERAPEUTICS INC (JSPR) is 14.